BÜHLMANN fCAL® ELISA Citation
Berinstein, J. et al. The Clinical Accuracy of the BÜHLMANN fCAL® ELISA in the Differentiation of Inflammatory Bowel Disease from Irritable Bowel Syndrome: A Multi-Center Prospective Case-Control Study. Crohn’s & Colitis 360 (2019). DOI: https://doi.org/10.1093/crocol/otz037. [Accepted Manuscript]
BÜHLMANN fCAL® ELISA is FDA 510(k) cleared For in vitro Diagnostic Use.
